Gorham-stout disease with clinical response to sirolimus treatment

8Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Gorham-Stout disease (GSD) is a rare clinical entity of unknown aetiology, with osseous resorption, vascular structure proliferation and inflammation of adjacent soft tissues. The clinical spectrum varies from asymptomatic patients to patients with pain, functional limitation or deformity. GSD may affect 1 or multiple bones in any location; however, predilection for the maxillofacial area and upper limbs has been described. We present the case report of a 33-year-old male patient with facial pain and loss of dental pieces; imaging showed extensive lytic involvement of the mandible and cranial bones. After exclusion of malignant, metabolic, infectious, or autoimmune disease, a diagnosis of GSD was made. Treatment with sirolimus was prescribed, achieving a symptomatic improvement and stability of imaging findings. The importance of the knowledge of this orphan disease is highlighted, to achieve a prompt diagnosis and medical treatment.

Cite

CITATION STYLE

APA

Saldarriaga, S. F., Vallejo, C., Pineda, L. U., Osma, A., & Gonzalez, C. B. (2021). Gorham-stout disease with clinical response to sirolimus treatment. European Journal of Case Reports in Internal Medicine, 8(8). https://doi.org/10.12890/2021_002740

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free